The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects

Cerebral Cortex

Volumn 22, Issue 11, 2012, Pages 2653-2661

  Sabuncu, Mert R ^a,b   Buckner, Randy L ^a,c,d   Smoller, Jordan W ^a   Lee, Phil Hyoun ^a   Fischl, Bruce ^a,b   Sperling, Reisa A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Alzheimer's disease; imaging genetics; polygenic score

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; POLYGENIC SCORE; PREDICTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; THICKNESS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; CEREBRAL CORTEX; DATABASES, GENETIC; DISEASE PROGRESSION; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES; NEUROIMAGING; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 84867307852     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhr348     Document Type: Article

References (84)

1. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, et al. 2011. Amyloid-b associated cortical thinning in clinically normal elderly. Ann Neurol. 69:1032-1042.
2. Bertram L, Tanzi RE. 2009. Genome-wide association studies in Alzheimer's disease. Hum Mol Genet. 18:R137-R145.
3. Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmansky N, Salat D, Rosand J. 2010. Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol. 67:677-685.
4. Browning BL, Browning SR. 2009. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet. 84:210-223.
5. Buerger K, Ewers M, PirttiläT, Zinkowski R, Alafuzoff I, Teipel SJ, DeBernardis J, Kerkman D, McCulloch C, Soininen H, et al. 2006. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain. 129:3035-3041. (Pubitemid 44684523)
6. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD, et al. 2009. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet. 41:192-198.
7. Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, et al. 2007. Correlations between apolipoprotein E e 4 gene dose and whole brain atrophy rates. Am J Psychiatry. 164:916-921. (Pubitemid 46972907)
8. Chiti F, Dobson CM. 2006. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 75:333-366. (Pubitemid 44118036)
9. Cordell HJ. 2009. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 10:392-404.
10. Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC. 2005. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage. 25:783-792. (Pubitemid 40461717)
11. De Meyer GD, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, et al. 2010. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol. 67:949-956.
12. Desikan RS, Sabuncu MR, Schmansky NJ, Reuter M, Cabral HJ, Hess CP, Weiner MW, Biffi A, Anderson CD, Rosand J, et al. 2010. Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One. 5:e12853.
13. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, et al. 2006. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 31:968-980. (Pubitemid 44183792)
14. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, et al. 2009. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 19:497-510.
15. Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, Kramer JH, Mungas D, Yaffe K, Chui HC, et al. 2003. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology. 61:481-486. (Pubitemid 36188246)
16. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, et al. 2006. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Ab42 in humans. Ann Neurol. 59:512-519. (Pubitemid 43358072)
17. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE. 2009. Distinct patterns of brain activity in young carriers of the APOE-'4 allele. Proc Natl Acad Sci USA. 106:7209-7214.
18. Fischl B, Liu A, Dale AM. 2001. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging. 20:70-80. (Pubitemid 32293421)
19. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, et al. 2002. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 33:341-355. (Pubitemid 34162530)
20. Fischl B, Sereno MI, Dale AM. 1999. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage. 9:195-207. (Pubitemid 29369875)
21. Fischl B, Sereno MI, Tootell RB, Dale AM. 1999. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 8:272-284.
22. Fleisher AS, Sherzai A, Taylor C, Langbaum JB, Chen K, Buxton RB. 2009. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage. 47:1678-1690.
23. Fox NC, Freeborough PA, Rossor MN. 1996. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet. 348:94-97. (Pubitemid 26234357)
24. Fox NC, Scahill RI, Crum WR, Rossor MN. 1999. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology. 52:1687-1689. (Pubitemid 29220648)
25. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, RossorMN. 1996. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain. 119:2001-2007.
26. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. 2010. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 6:67-77.
27. Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, Posner SF, Viitanen M, Winblad B, Ahlbom A. 1997. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci. 52:M117-M125. (Pubitemid 27123973)
28. Gómez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. 1996. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 16:4491-4500. (Pubitemid 26243044)
29. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. 1986. Abnormal phosphorylation of the microtubuleassociated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA. 83:4913-4917.
30. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al. 2009. Genomewide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 41:1088-1093.
31. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, et al. 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 43:429-435.
32. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. 2010. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9:119-128.
33. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E. 1999. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1397-1403. (Pubitemid 29190530)
34. Jack CR Jr, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E. 1997. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 49:786-794. (Pubitemid 27428023)
35. Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, et al. 2005. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 65:1227-1231. (Pubitemid 41508215)
36. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. 2006. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol. 59:673-681.
37. Kelly BL, Ferreira A. 2007. Beta-amyloid disrupted synaptic vesicle endocytosis in culturedhippocampal neurons.Neuroscience.147:60-70. (Pubitemid 46876699)
38. Klöppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS. 2008. Automatic classification of MR scans in Alzheimer's disease. Brain. 131:681-689. (Pubitemid 351294712)
39. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, et al. 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 55:306-319. (Pubitemid 38269583)
40. Laakso MP, Soininen H, Partanen K, Helkala EL, Hartikainen P, Vainio P, Hallikainen M, Hänninen T, Riekkinen PJ Sr. 1995. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect. 9:73-86.
41. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, et al. 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 41:1094-1099.
42. Marcus DS, Wang TH, Parker J, Csernansky JG, Morris JC, Buckner RL. 2007. Open Access Series of Imaging Studies (OASIS): crosssectional MRI data in young, middle aged, nondemented, and demented older adults. J Cogn Neurosci. 19:1498-1507. (Pubitemid 47358152)
43. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 42:85-94. (Pubitemid 27304784)
44. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC. 2006. [11C] PIB in a nondemented population. Neurology. 67:446-452.
45. Mori E, Lee K, Yasuda M, Hashimoto M, Kazui H, Hirono N, Matsui M. 2002. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E e 4 allele. Ann Neurol. 51:209-214. (Pubitemid 34111443)
46. Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA. 2010. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 67:122-131.
47. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, et al. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 43:436-441.
48. O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R; Texas Alzheimer's Research Consortium. 2008. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol. 65:1091-1095.
49. Pedersen NL. 2010. Reaching the limits of genome-wide significance in Alzheimer disease: back to the environment. JAMA. 303:1864-1865.
50. Pedersen NL, Gatz M, Berg S, Johansson B. 2004. How heritable is Alzheimer's disease late in life? Findings from Swedish twins. Ann Neurol. 55:180-185. (Pubitemid 38166994)
51. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC. 2007. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain. 130:2837-2844. (Pubitemid 350033975)
52. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 38:904-909. (Pubitemid 44141658)
53. Price JL, Morris JC. 1999. Tangles and plaques in nondemented aging and preclinical Alzheimer's disease. Ann Neurol. 45:358-368. (Pubitemid 29120041)
54. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly mJ, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 81:559-575. (Pubitemid 47330214)
55. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P, Purcell SM, Stone JL, Sullivan PF, et al. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 460:748-752.
56. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. 2004. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA. 101:284-289. (Pubitemid 38084242)
57. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, De Leon MJ, De Santi S, Convit A, Osborne D, Weaver A, et al. 1998. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol. 44:288-291. (Pubitemid 28374124)
58. Reuter M, Fischl B. 2011. Avoiding asymmetry-induced bias in longitudinal image processing. Neuroimage. 57:19-21.
59. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC. 2006. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 5:828-834. (Pubitemid 44715810)
60. Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, et al. 2011. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol. 68:1040-1048.
61. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. 1993. Association of apolipoprotein E allele e 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1467-1472. (Pubitemid 23230526)
62. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C; Medical Research Council Cognitive Function and Ageing Study. 2009. Age, neuropathology, and dementia. N Engl J Med. 360:2302-2309.
63. Schott JM, Bartlett JW, Fox NC, Barnes J; Alzheimer's Disease Neuroimaging Initiative Investigators. 2010. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Ab1-42. Ann Neurol. 68:825-834.
64. Ségonne F, Pacheco J, Fischl B. 2007. Geometrically accurate topologycorrection of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging. 26:518-529. (Pubitemid 46527332)
65. Selkoe DJ. 2004. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol. 6:1054-1061. (Pubitemid 39468006)
66. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, et al. 2010. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 303:1832-1840.
67. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, et al. 2009. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 65:403-413.
68. Sheline YI, Morris JC, Snyder AZ, Price JL, Yan Z, D'Angelo G, Liu C, Dixit S, Benzinger T, Fagan A, et al. 2010. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A b 42. J Neurosci. 30:17035-17040.
69. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, et al. 2000. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 97:6037-6042. (Pubitemid 30367519)
70. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, et al. 2011. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 7:280-292.
71. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in lateonset familial Alzheimer disease. Proc Natl Acad Sci USA. 90:1977-1981. (Pubitemid 23069980)
72. Thorisson GA, Smith AV, Krishnan L, Stein LD. 2005. The international HapMap project web site. Genome Res. 15:1592-1593. (Pubitemid 41545013)
73. Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM. 2010. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE '4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimer's Dis. 22:307-313.
74. van Es MA, van den Berg LH. 2009. Alzheimer's disease beyond APOE. Nat Genet. 41:1047-1048.
75. Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, Ackermann U, Cowie TF, Currie J, Chan SG, et al. 2008. A b deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia. 46:1688-1697.
76. Villemagne VL, Pike KE, Ché telat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, et al. 2011. Longitudinal assessment of Ab and cognition in aging and Alzheimer disease. Ann Neurol. 69:181-192.
77. Waring SC, Rosenberg RN. 2008. Genome-wide association studies in Alzheimer disease. Arch Neurol. 65:329-334. (Pubitemid 351409357)
78. Wechsler D. 1987. Manual for the Wechsler memory scale-revised. San Antonio (TX): Psychological Corporation
79. Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J, Prendergast GC. 1997. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem. 272:31453-31458. (Pubitemid 28013284)
80. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr. 2007. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain. 130:1777-1786. (Pubitemid 47343806)
81. Wigge P, Köhler K, Vallis Y, Doyle CA, Owen D, Hunt SP, McMahon HT. 1997. Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell. 8:2003-2015. (Pubitemid 27451117)
82. Wishart H, Saykin A, McAllister T, Rabin L, McDonald B, Flashman L, Roth R, Mamourian A, Tsongalis G, Rhodes C. 2006. Regional brain atrophy in cognitively intact adults with a single APOE e 4 allele. Neurology. 67:1221-1224. (Pubitemid 44563831)
83. Wolk DA, Dickerson BC. 2010. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci USA. 107:10256-10261.
84. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. 2009. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 106:14670-14675.